Summary All-trans-retinoic acid (RA), like insulin-like growth factor I (IGF-I) and tamoxifen, inhibit invasion of human MCF-7/6 mammary cancer cells in vitro. For tamoxifen and for IGF-I, activation of the invasion-suppressor function of the E-cadherin/catenin complex was shown to be the most probable mechanism of the anti-invasive action. We did a series of experiments to determine whether the anti-invasive effect of RA also implicated the invasion-suppressor E-cadherin/catenin complex. Human MCF-7/6 mammary and HCT-8/R1 colon cancer cells, both with a dysfunctional E-cadherin/catenin complex, were treated with RA and the function of the complex was evaluated through Ca2+-dependent fast aggregation. Fast aggregation of both MCF-7/6 and HCT-8/RI cells was induced by 1 gtM RA. This effect was abolished by antibodies against E-cadherin. RA-induced fast aggregation was not sensitive to cycloheximide, tyrosine kinase inhibitors or antibodies against IGF-I or against the IGF-I receptor. RA did not stimulate IGF-I receptor phosphorylation or alter the E-cadherin/catenin complex, as evidenced by immunoprecipitation. RA up-regulates the function of the invasion-suppressor complex E-cadherin/catenin. Its action mechanism is different from that of IGF-I. RA may act as an anti-invasive agent with unique mechanisms of action.
new models have been described for the homophilic interactions between the extracellular domains of cadherins (Overduin et al., 1995; Shapiro et al., 1995) . Experiments both in vivo and in vitro (Van Roy et al., 1992; Bracke et al., 1993) have suggested that the invasionsuppressor function of the E-cadherin/catenin complex is modulated by external factors. In human MCF-7/6 breast cancer cells IGF-I (Bracke et al., 1993) and the anti-estrogen tamoxifen (Bracke et al., 1994a) up-regulated the adhesive function of the E-cadherin/catenin complex and inhibited invasion in vitro. Inhibition of invasion of MCF-7/6 cells was also obtained with RA (Bracke et al., 1991) . We therefore wanted to examine whether RA could up-regulate the adhesive function of the E-cadherin/catenin complex. We have also examined the effect of RA on the components of the E-cadherin/catenin complex, using immunoprecipitation of metabolically labelled. cells. Finally, since the literature mentions that RA modulates IGF-I as well as IGF-binding proteins (IGFBPs) (Fontana et al., 1991; Figueroa and Yee, 1992) , we have tested possible relationships between IGF-Imediated regulation of E-cadherin/catenin functions and effects of RA. The general purpose of our work is to find agents that activate invasion-suppressor molecules and are therefore candidates for chronic anti-invasive treatment of cancer.
Materials and methods

Cells
The MCF-7/6 cell line (obtained from Dr H Rochefort, Unite d'Endocrinologie Cellulaire et Moleculaire, Montpellier, France) is a variant of the human MCF-7 breast cancer cell family. MCF-7/6 cells were treated with 1 jig ml-' mycoplasma removal agent (ICN Biomedicals, Costa Mesa, CA, USA) for seven passages. For the present experiments the cells were harvested from mycoplasma-free stock cultures maintained as described previously (Bracke et al., 1991) . The HCT-8/R1 cell line is a subclone from the human HCT-8 colon cancer cell line (CCL244, ATCC, Rockville, MD, USA) that was selected for its round morphotype. cells were maintained in RPMI-1640, supplemented with 1 mM sodium pyruvate and 100 fig ml-1 streptomycin. MCF-7/6 (Bracke et al., 1991 and HCT-8/R1 cells (Vermeulen et al., 1994) are invasive and have a dysfunctional E-cadherin/catenin complex, i.e. unable to mediate fast Ca2 + -dependent homotypic aggregation. MDA-MB-23 1 (ATCC; HTB26) cells were maintained in Leibovitz-15 medium, supplemented with 0.05% glutamine. These cells do not express E-cadherin (Frixen et al., 1991) . All culture media (Gibco, Gent, Belgium) were supplemented with 10% fetal bovine serum (FBS) and 250 IU ml-' penicillin.
Drugs
All-trans-retinoic acid (RA; Sigma, St Louis, MO, USA) was dissolved in ethanol at 1 mM and used at concentrations between 0.1 nM and 1 iLM. Control cultures were treated with corresponding ethanol concentrations. To study the role of de novo protein synthesis cells were treated with cycloheximide (Sigma) at 1Olg ml -. Recombinant human IGF-I was from Boehringer Mannheim (Brussels, Belgium). As tyrosine Antibodies MB2 and HECD-1 (Takara Shuzo, Kyoto, Japan) are monoclonal antibodies against human E-cadherin with neutralising effects on E-cadherin functions . aIR3 and 82-9A (Oncogene Science, Uniondale, NY, USA), are monoclonal antibodies functionally blocking respectively the human IGF-I receptor (Cullen et al., 1990; Bracke et al., 1993) Gent, Gent, Belgium) corresponding to the C-terminal part of mouse P-catenin (Butz et al., 1992 aggregation and lysed after 10 min using the lysis buffer described previously with the following protease inhibitors (all from Sigma): phenylmethylsulphonyl fluoride (1.72 mM), leupeptin (21 JiM), aprotinin (10 fig ml- (1987) with the following modifications. Cells were washed three times in phosphate-free EMEM with 2% dialysed FBS (Gibco) followed by labelling with 0.5 mCi ml-I carrier-free
[32P]orthophosphate (Amersham, Gent, Belgium) for 2 h. Cells were lysed in the presence of the following phosphatase inhibitors (all from Sigma): sodium pyrophosphate (10 mM); sodium fluoride (10 mM); sodium vanadate (1 mM). Phosphotyrosine molecules were immunoprecipitated with PY20 (5 fig per precipitation), immune complexes were washed three times with 750 l of lysis buffer and molecules were eluted three times for 15 min with 250 lal elution buffer containing: phospho-L-tyrosine (10 mM) and phenylphosphate (10 mM) in lysis buffer. Eluted molecules were immunoprecipitated with aIR3 (1 jig per precipitation) and proteins were analysed as described with the E-cadherin/catenin complex. IGFBPs were evaluated by ligand blotting (Fontana et al., 1991) . Briefly, cells were washed 5 times with serum-free medium followed by incubation for 44 h in the same medium. The conditioned medium was dialysed against 1.5 mM Tris and concentrated 100 times by lyophilisation. Lyophilised proteins were denatured with sodium dodecyl sulphate under non-reducing conditions, separated on 12% polyacrylamide gels and electroblotted. IGFBPs were visualised by ['251IlGF-I (Hossenlopp et al., 1986 3). RA also induced E-cadherin-specific fast aggregation in HCT-8/R1 cells lacking a-catenin, although to a lesser extent than in MCF-7/6 cells ( Figure 1) . The E-cadherin-negative MDA-MB-231 cells showed Ca2+-independent fast aggregation that was hardly altered by RA or by an antibody against E-cadherin (Figure 1 ). RA-induced fast aggregation of MCF-7/6 cells was not inhibited by cycloheximide at concentrations that reduced Tran35S incorporation to less than 15% of untreated controls (Figure 4 ). It was lowered by antibodies functionally blocking E-cadherin but not by antibodies against other surface molecules, ( tyrosine kinase inhibitors Genistein (25 tiM), Me-2,5-dihydroxycinnamate (50 tiM), RCAM-lysozyme (1 tIM) or 2-OH-5-(2,5-diOH-benzyl)aminobenzoic acid (10 tiM) (Table I) , although such concentrations inhibited IGF-I-induced fast aggregation (Bracke et al., 1994b) . The total amount of IGFBPs in medium conditioned for 44 h from MCF-7/6 cells treated with RA at 0.1 tIM was 1.1 and 1.5 times (two independent experiments) higher than in medium from untreated cultures. 
Discussion
We report that RA, at anti-invasive concentrations, induces fast aggregation of cells which have a dysfunctional Ecadherin/catenin complex. This induction was prevented by monoclonal antibodies that functionally blocked E-cadherin but not by other antibodies also binding to the cell surface. For MCF-7/6 breast cancer cells, induction of E-cadherindependent fast aggregation was achieved also with IGF-I (Bracke et al., 1993), with tamoxifen (Bracke et al., 1994a) and with the citrus flavonoid tangeretin (Bracke et al., 1994b) . All these agents inhibited invasion of MCF-7/6 cells in organ culture confirming the invasion-suppressor function of the E-cadherin/catenin complex . Ecadherin is known to act as an organiser of junctional complexes. It might be that the rapid and reversible cell type-and concentration-related up-or down-modulation of gap-junctional communication by RA (Mehta et al., 1989) occurs via modulation of the E-cadherin/catenin complex. Induction of the epithelioid morphotype and of E-cadherin expression at the cell-cell contact sites was reported with human SK-BR-3 mammary cancer cells treated with RA (Anzano et al., 1994) . RA-induced fast aggregation also occurred in the absence of de novo protein synthesis, as demonstrated by our experiments with cycloheximide. This suggests that RA, in association with its receptors or not, interacts directly with the E-cadherin/catenin complex or its effectors. It does not, however, exclude the possibility that RA acts via binding to hormone-sensitive elements, leading to arrest of transcription of an inhibitory protein. The fact that cycloheximide by itself has no effect on fast aggregation argues against the latter possibility.
The relatively high concentrations (1-0.1 M) of RA needed to induce fast aggregation are similar to those des-
AI-trans-rinoic acid activates E-cadherin function SJ Vermeulen et al cribed for the decrease in B 16 melanoma cell aggregation (Edward et al., 1992) and for down-regulation of P4 integrins in LL4 cells (Gaetano et al., 1994) . This need may be ascribed to the presence of serum in the culture medium and of albumin in the salt solution used for the aggregation assay (see Materials and methods) . Albumin is known to bind RA as it serves as its carrier protein in the blood (Allen and Bloxham, 1989) . Our co-immunoprecipitation data failed to demonstrate an effect of RA on the composition of the E-cadherin/catenin complex. This observation suggests that the cause of dysfunction of E-cadherin in MCF-7/6 cells is situated downstream of the E-cadherin/catenin complex. The fact that RA also induced E-cadherin-dependent fast aggregation, although less effectively, in x-catenin-deficient HCT-8/R1 cells supports the idea of a downstream defect in MCF-7/6 cells.
RA does not seem to interact directly with IGFBPs, IGF-I or the IGF-I receptor, all of which are implicated in IGF-Imediated aggregation of MCF-7/6 cells ). An action via an autocrine IGF-I loop is unlikely because antibodies functionally blocking IGF-I did not hamper RAinduced aggregation. Neither could it be inhibited with antibodies against the IGF-I receptor nor did phosphorylation of the IGF-I receptor occur upon RA treatment in contrast to addition of IGF-I. Moreover, the tyrosine kinase inhibitors that blocked IGF-I-induced fast aggregation had no effect on RA-induced aggregation. It is unlikely that the slight increase in IGFBPs found in our and in others' experiments (Fontana et al., 1991; Yee et al., 1994) All-trans-rtinoic acid activates E-cadherin function SJ Vermeulen et al 1452 activity of RA on MCF-7/6 cells as described previously (Bracke et al., 1991) . It is, however, unlikely that this is the only mechanism of the anti-invasive action of RA. Such action was described also for melanoma (Helige et al., 1993) and rhabdomyosarcoma (Gerharz et al., 1993 ) cells which are not expected to express E-cadherin. RA did not inhibit, however, the invasion of the E-cadherin-negative MDA-MB-231 cells into chick heart (our unpublished results). This shows the existence of alternative mechanisms of antiinvasiveness such as inhibition of proteolytic enzymes (Gudas et al., 1994; Yamamoto et al., 1995) .
Taken together, our results indicate that RA-induced aggregation of MCF-7/6 cells via the E-cadherin/catenin complex depends upon a mechanism other than IGF-I-induced aggregation. This novel function, namely the activation of a dysfunctional E-cadherin/catenin complex via a protein synthesis-independent mechanism, might identify RA as a potential anti-invasive agent for combinatorial cancer treatment.
